Baycol drugs lower cholesterol by blocking a specific enzyme which is used in the synthesis of cholesterol. Bayer Pharmaceutical Division withdrew this drug from the market on August 8, 2001 because of increased reports of sometimes fatal rhabdomyolysis. Rhabdomyclysis is a condition which results in muscle cell breakdown and release of the contents of the muscle cells into the bloodstream. This condition can lead to kidney failure, multi-organ failure, and death.
Find Baycoll Attorneys:
If you have been injured because of the drug Baycoll,click on our find an attorney form to locate a lawyer in your state who can help you maximize your claim for money damages.
Baycol Case Evaluation Form
Pharmaceutical Dates on the market: 6/26/97 – 8/8/01
Indication for use: Treatment of high cholesterol
Serious Adverse Events:
Rhabdomyolysis (skeletal muscle destruction) Kidney Failure
Symptoms of this condition include: muscle pain, weakness, fever, dark urine, nausea and vomiting. There have been over 480 reports of rhabdomyolysis and 31 deaths associated with Baycol reported to the FDA.